Human T cell recognition of cloned HL A class I gene products expressed on DNA transfectants of mouse mastocytoma P815

1985 ◽  
Vol 15 (11) ◽  
pp. 1111-1117 ◽  
Author(s):  
Janet L. Maryanski ◽  
Alessandro Moretta ◽  
Bertrand Jordan ◽  
Etienne de Plaen ◽  
Aline van Pel ◽  
...  
2002 ◽  
Vol 169 (4) ◽  
pp. 1887-1892 ◽  
Author(s):  
Vladimir Janković ◽  
Kristin Remus ◽  
Alberto Molano ◽  
Janko Nikolich-Žugich

1993 ◽  
Vol 177 (3) ◽  
pp. 869-873 ◽  
Author(s):  
W Chen ◽  
J McCluskey ◽  
S Rodda ◽  
F R Carbone

Recent crystallographic studies on two peptide complexes with the mouse Kb molecule have shown that peptide binding appears to alter the conformation of the class I alpha-helical regions that flank the antigen binding cleft. Given that this study also showed that much of the foreign peptide is buried within the class I binding cleft with only a small portion accessible for direct interaction with the components of the T cell receptor, this finding suggests that at least some component of T cell specificity may arise as a consequence of peptide-induced conformational changes in the class I structure. To assess this possibility, we have made systematic substitutions at residues within the Kb-restricted determinant from ovalbumin (OVA257-264) that are thought to be buried on binding to the class I molecule. We have found that changes in this determinant at the completely buried second residue (P2) can influence T cell recognition without affecting binding to Kb, suggesting that the substitutions may indirectly determine T cell recognition by altering the conformation of the class I molecule or the bound peptide.


mBio ◽  
2014 ◽  
Vol 5 (1) ◽  
Author(s):  
Richard Copin ◽  
Mireia Coscollá ◽  
Salome N. Seiffert ◽  
Graham Bothamley ◽  
Jayne Sutherland ◽  
...  

ABSTRACTTheMycobacterium tuberculosisgenome includes the large family ofpe_pgrsgenes, whose functions are unknown. Because of precedents in other pathogens in which gene families showing high sequence variation are involved in antigenic variation, a similar role has been proposed for thepe_pgrsgenes. However, the impact of immune selection onpe_pgrsgenes has not been examined. Here, we sequenced 27pe_pgrsgenes in 94 clinical strains from five phylogenetic lineages of theM. tuberculosiscomplex (MTBC). We found thatpe_pgrsgenes were overall more diverse than the remainder of the MTBC genome, but individual members of the family varied widely in their nucleotide diversity and insertion/deletion (indel) content: some were more, and others were much less, diverse than the genome average. Individualpe_pgrsgenes also differed in the ratio of nonsynonymous to synonymous mutations, suggesting that different selection pressures act on individualpe_pgrsgenes. Using bioinformatic methods, we tested whether sequence diversity inpe_pgrsgenes might be selected by human T cell recognition, the major mechanism of adaptive immunity to MTBC. We found that the large majority of predicted human T cell epitopes were confined to the conserved PE domain and experimentally confirmed the antigenicity of this domain in tuberculosis patients. In contrast, despite being genetically diverse, the PGRS domains harbored few predicted T cell epitopes. These results indicate that human T cell recognition is not a significant force driving sequence diversity inpe_pgrsgenes, which is consistent with the previously reported conservation of human T cell epitopes in the MTBC.IMPORTANCERecognition ofMycobacterium tuberculosisantigens by T lymphocytes is known to be important for immune protection against tuberculosis, but it is unclear whether human T cell recognition drives antigenic variation inM. tuberculosis. We previously discovered that the known human T cell epitopes in theM. tuberculosiscomplex are highly conserved, but we hypothesized that undiscovered epitopes with naturally occurring sequence variants might exist. To test this hypothesis, we examined thepe_pgrsgenes, a large family of genes that has been proposed to function in immune evasion byM. tuberculosis. We found that thepe_pgrsgenes exhibit considerable sequence variation, but the regions containing T cell epitopes and the regions of variation are distinct. These findings confirm that the majority of human T cell epitopes ofM. tuberculosisare highly conserved and indicate that selection forces other than T cell recognition drive sequence variation in thepe_pgrsgenes.


2006 ◽  
Vol 176 (11) ◽  
pp. 6673-6680 ◽  
Author(s):  
David R. Fooksman ◽  
Gigi Kwik Grönvall ◽  
Qing Tang ◽  
Michael Edidin

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 1811-1811
Author(s):  
Eleanor M. Lanning ◽  
Peter G. Middleton ◽  
Anne M. Dickinson ◽  
Ernst Holler ◽  
Eliane Gluckman ◽  
...  

Abstract On behalf of Eurobank Members CD1a is a lipid antigen-presenting protein related to MHC class I that is frequently but incorrectly said to be non-polymorphic. There are two alleles in humans that differ by two linked amino acid substitutions, I13T and W51C in the alpha-1 domain. Substitution of threonine and cysteine in the minor allele may modify the structure of the antigen-binding groove and influence antigen specificity and T cell recognition. The CD1a gene on chromosome 1 may be mismatched in MHC identical sibling transplants, but the effect of this on GVHD is unknown. We hypothesized that CD1a might act as a tissue antigen and that GVHD would increase in recipients who possessed an allele unknown to the donor. 163 recipient-donor sibling pairs transplanted with full and reduced intensity conditioning but without T depletion were identified from a database of all sequential transplants performed in Newcastle from Nov 1984 to Sept 2004 and in collaborating Eurobank centres from Nov 1997 to Sept 2004. DNA was amplified by PCR primers 5′: CCTGGAAACAAAATCTGGTC and 3′: GGGTACTTAACGTCAAACTT producing a 209 bp fragment, encompassing the C to G substitution at nucleotide 738 (W51C). This was analysed by SSCP and RFLP using the Hae III site 737–741. The overall allele frequency was: allele 1 (I13; W51): 0.07; allele 2 (T13; C51): 0.93. 148 pairs were matched at CD1a (2,2 into 2,2 or 1,2 into 1,2) and 15 were unmatched in the GVHD direction (2,2 into 1,2). There were no significant differences between the cohorts in age, gender mismatch, conditioning or transplant center. 5 year projected survival was 57% months in the matched cohort and 59% months in the unmatched (p=0.10 Kaplan-Meier). 43/148 (29%) matched transplants received cyclosporin alone GVHD prophylaxis compared with 9/15 (60%) of unmatched transplants (p=0.01; Fisher’s exact test). The incidence and severity of GVHD was similar in both matched and unmatched cohorts: grade I–IV: 81% and 87% respectively (p=0.59); II–IV: 61% and 62% (p=0.48); III–IV: 22% and 20% (p=0.51; Fisher’s exact test). The use of less GVHD prophylaxis in the unmatched group strengthens a negative result and as predicted, no increase in risk due to mismatching was revealed after correction for GVHD prophylaxis and other variables by binomial logistic regression. CD1a is an antigen-presenting molecule important in host defense. It is dimorphic in humans with a minor allele found in 16% of individuals and mismatched in the GVHD direction in 9% of HLA-identical sibling allogeneic transplants. Although amino acid substitution may alter the antigen specificity of the two isoforms of CD1a, mismatching does not increase the risk of GVHD and therefore CD1a does not appear to function as a tissue antigen in transplantation. This functional result supports recent structural analysis of the CD1a-TCR interaction showing that the glycolipid antigen makes little contribution to TCR binding, in contrast to the peptide antigens of conventional class I MHC molecules, which play an essential role in T cell recognition (Zajonc et al. Immunity2005. 22: 209–19).


2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 2578-2578
Author(s):  
C. Renner ◽  
G. Held ◽  
F. Neumann ◽  
S. Kleber ◽  
M. Thiel ◽  
...  

2578 Background: Vaccine strategies that target or activate dendritic cells in order to elicit potent cellular immunity are currently the subject of intense research. Here we report that genetically engineered yeast expressing the full-length tumor associated antigen NY-ESO-1 are a versatile host for protein production eliciting MHC class I and II T-cell responses. Methods: The pYD1 yeast display vector was chosen for full length NY-Eso-1 protein (pNY-ESO-1) expression. NY-ESO-1 and SSX-2 (as control) protein were affinity purified on. IFN-g ELISPOT assays were performed in triplicates on nitrocellulose-lined 96-well plates. MHC class I cross-presentation of peptide epitopes was demonstrated by blocking T-cell responses against DCs. For this purpose, antigen or peptide pulsed DCs were labeled with different doses (100, 10, 1 μg/ml) of antibodies specific for HLA-A2/peptide complexes (HLA-A2/ NY-Eso-1157–165; 3M4E5) or an irrelevant antibody (specific for HLA-A2/IMP58–66) as control. Results: Highest level of NY-ESO-1 expression was detected on the cell wall of wt EBY100 strain with lower expression levels on PMT deficient strains PMT-2 and PMT-4. After protein feeding of immature DCs, NY-ESO-1 157–165 peptide cross-presentation was detected by 3M4E5 and an antigen-specific CD8+ T cell clone. There was a strong positive correlation between the amount of Aga2p-NY-ESO-1 protein (0–15μg/ml) and peptide presentation. Specific T-cell recognition of NY-Eso-1 157–165/HLA-A2 complexes was validated by blocking experiments with Fab 3M4E5. Pre-incubation of protein fed DCs with the antibody at different concentrations (0–100 μg/ml) resulted in a significant reduction (p< 0.05) of spot numbers. Efficient presentation and T-cell recognition of epitope 157–165 was only adequately detectable when protein produced by EBY100 wt yeast strain was used (p < 0.05). MHC class II presentation was studied in an autologous setting using a T-cell line recognising the NY-ESO-1 157–170 in HLA-DP4 context revealing that NY-ESO-1 protein produced in yeast was efficiently taken up and presented. Conclusions: Together, these data add further evidence that yeast expressing recombinant proteins can be used for vaccine purposes and that antigen uptake in APC depends on glycoslation of yeast expressed antigens. No significant financial relationships to disclose.


Sign in / Sign up

Export Citation Format

Share Document